Showing results (1231-1240 of 1,319) with videos related to

Sort By:
Pageof 132
Nature Genetics|November 1, 1996
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2S M Pulst, A Nechiporuk, T Nechiporuk, et al.
Scientific Reports|October 3, 2018
Experimental evidence for the enhanced and reduced stopping regimes for protons propagating through hot plasmasS N Chen, S Atzeni, T Gangolf, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 20, 2026
[Clinical characteristics and prognostic analysis of adult KMT2A-associated acute myeloid leukemia]X Y Zhou, X E Wei, Y Liu, et al.
Genetics and Molecular Research : GMR|October 20, 2012
Carcass and meat quality traits of four commercial pig crossbreeds in ChinaY Z Jiang, L Zhu, G Q Tang, et al.
Frontiers in Oncology|May 21, 2016
Intensity-Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: The Georgetown University ExperienceCatherine Mercado, Marie-Adele Kress, Robyn A Cyr, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 6, 2025
The 2025 American Association for Thoracic Surgery (AATS) Expert Consensus Document: Surgical Management of Esophageal and Gastroesophageal Junction CancerD Molena, M Sewell, S B Maron, et al.
Nanotechnology|September 17, 2009
Fluorescence signals of quantum dots influenced by spatially controlled array structuresJ W Chou, K C Lin, Y T Tang, et al.
Physical Review Letters|December 7, 2019
Laser-Produced Magnetic-Rayleigh-Taylor Unstable Plasma Slabs in a 20 T Magnetic FieldB Khiar, G Revet, A Ciardi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 7, 2022
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLCA A Bokhari, W-Y Lai, A T Le, et al.
Radiation Oncology (London, England)|December 16, 2014
Proctitis following stereotactic body radiation therapy for prostate cancerDaniel Y Joh, Leonard N Chen, Gerald Porter, et al.
Pageof 132